Mpm Bioimpact LLC’s Corvus Pharmaceuticals Inc Position
Does Mpm Bioimpact LLC own Corvus Pharmaceuticals Inc (CRVS)? Yes — 1.67M shares worth $25M (+1.89% of its 13F portfolio) as of Q1 2026, down from 2.74M shares the prior filed quarter.
Position Value
$25M
Q1 2026
Shares
1.67M
% of Portfolio
+1.89%
Quarters Held
2
currently held
Position History CRVS
Reported value by quarter
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Mpm Bioimpact LLC’s full portfolio or all institutional holders of CRVS.